SCHEMBL174526

SCHEMBL174526

CC(C)(C)C1C(Nc2c(N)nc(-c3nn(Cc4ccccc4F)c4ncccc34)nc2N)CN1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.57
KCNH2 Q12809 1/20 0.57
GUCY1A1 Q02108 16/20 0.51
GUCY1B1 Q02153 16/20 0.51
PDE5A O76074 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15732829 0.84 ADORA3 (0.61) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL12468165 0.83 ADORA3 (0.52) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL174527 0.81 ADORA3 (0.59) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL2009564 0.80 ADORA3 (0.68) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL18212217 0.79 ADORA3 (0.70) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL256215 0.79 ADORA3 (0.59) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
Dimethyl Sulfoxide SCHEMBL15152548 0.78 ADORA3 (0.66) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL20148914 0.78 ADORA3 (0.67) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL248358 0.78 ADORA3 (0.73) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A
SCHEMBL29379641 0.78 ADORA3 (0.73) ADORA3KCNH2GUCY1A1GUCY1B1PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611802-B1 BICYCLIC AZA-HETEROCYCLES AND THEIR USE BAYER IP GMBH (DE) 2016-02-24 EP disclosed
EP-2611802-A1 BICYCLIC AZA HETEROCYCLES, AND USE THEREOF Bayer Intellectual Property GmbH (DE) 2013-07-10 EP disclosed
WO-2012028647-A1 BICYCLIC AZA HETEROCYCLES, AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-08 WO disclosed